Applied Clinical Trials-08-01-2023

Increased adoption of decentralized trials and new advancements in technology among reasons for evolving regulatory landscape.

Stepped-up training and real-time application key to avoiding compliance pitfalls.

How to support trial investigators through decentralization of trial elements.

Agency provides update on decentralized trials and digital health technologies at DIA 2023.

Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.

eCOA and PRO consortiums along with regulators gather for discussion on important data collection topics.

In this Q&A, Dodd speaks about GeoVax's vaccine development strategy, clinical trials, and approach to serving patient populations often overlooked by conventional vaccines.

A look at the complexities—and potentially conflicting goals—in industry’s commitment to trial-result transparency.

The agency proposes significant revisions to oversight programs for drugs and medical products.

Changing the expectations of the feasibility study can improve the process.